|
🐜
|
Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era.
14 auth.
C. Gisselbrecht,
B. Glass,
N. Mounier,
Devinder Singh Gill,
D. Linch,
M. Trněný,
A. Bosly,
N. Ketterer,
O. Shpilberg,
H. Hagberg,
...
D. Ma,
J. Brière,
C. Moskowitz,
N. Schmitz
|
10 |
2010 |
10
🐜
|
|
🐜
|
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte.
16 auth.
P. Feugier,
A. Hoof,
C. Sebban,
P. Solal-Céligny,
R. Bouabdallah,
C. Fermé,
B. Christian,
É. Lepage,
H. Tilly,
F. Morschhauser,
...
P. Gaulard,
G. Salles,
A. Bosly,
C. Gisselbrecht,
F. Reyes,
B. Coiffier
|
10 |
2005 |
10
🐜
|
|
🐜
|
High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.
19 auth.
T. Philip,
J. Armitage,
G. Spitzer,
F. Chauvin,
S. Jagannath,
J. Cahn,
P. Colombat,
A. H. Goldstone,
N. Gorin,
M. Flesh,
...
J. Laporte,
D. Maraninchi,
J. Pico,
A. Bosly,
C. Anderson,
R. Schots,
P. Biron,
F. Cabanillas,
K. Dicke
|
9 |
1987 |
9
🐜
|
|
🐜
|
Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients.
7 auth.
P. Wijermans,
M. Lübbert,
G. Verhoef,
A. Bosly,
C. Ravoet,
M. André,
...
A. Ferrant
|
9 |
2000 |
9
🐜
|
|
🐜
|
Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).
14 auth.
N. Mounier,
J. Brière,
C. Gisselbrecht,
J. Emile,
P. Lederlin,
C. Sebban,
F. Berger,
A. Bosly,
P. Morel,
H. Tilly,
...
R. Bouabdallah,
F. Reyes,
P. Gaulard,
B. Coiffier
|
9 |
2003 |
9
🐜
|
|
🐜
|
Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA).
13 auth.
C. Gisselbrecht,
P. Gaulard,
É. Lepage,
B. Coiffier,
J. Brière,
C. Haioun,
D. Cazals‐Hatem,
A. Bosly,
L. Xerri,
H. Tilly,
...
F. Berger,
Réda Bouhabdallah,
J. Diebold
|
8 |
1998 |
8
🐜
|
|
🐜
|
Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study.
15 auth.
C. Haioun,
É. Lepage,
C. Gisselbrecht,
G. Salles,
B. Coiffier,
P. Brice,
A. Bosly,
P. Morel,
C. Nouvel,
H. Tilly,
...
P. Lederlin,
C. Sebban,
J. Brière,
P. Gaulard,
F. Reyes
|
8 |
2000 |
8
🐜
|
|
🐜
|
Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia
26 auth.
C. Graux,
J. Cools,
C. Melotte,
H. Quentmeier,
A. Ferrando,
R. Levine,
J. Vermeesch,
M. Stul,
B. Dutta,
N. Boeckx,
A. Bosly,
P. Heimann,
A. Uyttebroeck,
N. Mentens,
René Somers,
...
R. MacLeod,
H. Drexler,
A. Look,
D. Gilliland,
D. Gilliland,
D. Gilliland,
L. Michaux,
P. Vandenberghe,
I. Wlodarska,
P. Marynen,
A. Hagemeijer
|
8 |
2004 |
8
🐜
|
|
🐜
|
Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.
12 auth.
H. Tilly,
É. Lepage,
B. Coiffier,
M. Blanc,
R. Herbrecht,
A. Bosly,
...
M. Attal,
G. Fillet,
C. Guettier,
T. Molina,
C. Gisselbrecht,
F. Reyes
|
8 |
2003 |
8
🐜
|
|
🐜
|
Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial
22 auth.
C. Récher,
B. Coiffier,
C. Haioun,
T. Molina,
C. Fermé,
O. Casasnovas,
C. Thieblemont,
A. Bosly,
G. Laurent,
F. Morschhauser,
...
H. Ghesquières,
F. Jardin,
S. Bologna,
C. Fruchart,
B. Corront,
J. Gabarre,
C. Bonnet,
M. Janvier,
D. Canioni,
J. Jais,
G. Salles,
H. Tilly
|
8 |
2011 |
8
🐜
|
|
🐜
|
ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma.
12 auth.
F. Reyes,
É. Lepage,
G. Ganem,
T. Molina,
P. Brice,
B. Coiffier,
...
P. Morel,
C. Fermé,
A. Bosly,
P. Lederlin,
G. Laurent,
H. Tilly
|
8 |
2005 |
8
🐜
|
|
🐜
|
Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.
15 auth.
N. Mourad,
N. Mounier,
J. Brière,
E. Raffoux,
A. Delmer,
A. Feller,
C. Meijer,
Jean-François Emile,
R. Bouabdallah,
A. Bosly,
...
J. Diebold,
C. Haioun,
B. Coiffier,
C. Gisselbrecht,
P. Gaulard
|
8 |
2008 |
8
🐜
|
